1-4 of 4
Jason Jalil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Rong Rong Huang, Jason Jalil, James S. Economou, Bartosz Chmielowski, Richard C. Koya, Stephen Mok, Hooman Sazegar, Elizabeth Seja, Arturo Villanueva, Jesus Gomez-Navarro, John A. Glaspy, Alistair J. Cochran, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4101–4109.
https://doi.org/10.1158/1078-0432.CCR-11-0407
Published: 15 June 2011
View article titled, CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
Open the PDF for CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans in another window
Includes: Supplementary data
Journal Articles

The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations

Begoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, Douglas Matsunaga, Stephen Mock, Jason Jalil, Helena Escuin-Ordinas, Bartosz Chmielowski, Richard C Koya, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (24): 6040–6048.
https://doi.org/10.1158/1078-0432.CCR-10-1911
Published: 16 December 2010
View article titled, The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
Open the PDF for The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations in another window
Includes: Supplementary data
Journal Articles

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

Antoni Ribas, Begoña Comin-Anduix, Bartosz Chmielowski, Jason Jalil, Pilar de la Rocha, Tara A. McCannel, Maria Teresa Ochoa, Elizabeth Seja, Arturo Villanueva, Denise K. Oseguera, Bradley R. Straatsma, Alistair J. Cochran, John A. Glaspy, Liu Hui, Francesco M. Marincola, Ena Wang, James S. Economou, Jesus Gomez-Navarro
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6267–6276.
https://doi.org/10.1158/1078-0432.CCR-09-1254
Published: 30 September 2009
View article titled, Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Open the PDF for Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

Antoni Ribas, Begoña Comin-Anduix, James S. Economou, Timothy R. Donahue, Pilar de la Rocha, Lilah F. Morris, Jason Jalil, Vivian B. Dissette, Itsushi Peter Shintaku, John A. Glaspy, Jesus Gomez-Navarro, Alistair J. Cochran
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 390–399.
https://doi.org/10.1158/1078-0432.CCR-08-0783
Published: 31 December 2008
View article titled, Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
Open the PDF for Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade in another window
Includes: Supplementary data